GlassScriptPhysician profile
Brenda Ocampo
NPI 1902683352
$2,302.44
in general payments reported to CMS, 2019-2025
25 companies · $2,002 in 2025
The $2,002 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $300 · 2025: $2,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $297.63 | 2025 | |
| Journey Medical Corporation | $268.24 | 2025 | Emrosi |
| Arcutis Biotherapeutics, INC. | $246.58 | 2025 | Zoryve |
| Incyte Corporation | $214.42 | 2025 | Opzelura, Opzelura |
| Galderma Laboratories, L.P. | $205.33 | 2025 | Nemluvio, Aklief |
| Sun Pharmaceutical Industries INC. | $146.27 | 2025 | |
| Lilly USA, LLC | $143.35 | 2025 | Ebglyss |
| Abbvie INC. | $119.00 | 2024-2025 | |
| Genzyme Corporation | $97.64 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $88.44 | 2025 | Dupixent |
| Boston Scientific Corporation | $62.78 | 2024 | Rezum Generator |
| Telix Pharmaceuticals | $51.17 | 2024-2025 | Illuccix |
| Myriad Genetic Laboratories, INC. | $50.01 | 2024-2025 | Myrisk |
| Janssen Biotech, INC. | $37.98 | 2025 | Erleada |
| Tolmar, INC. | $36.50 | 2024-2025 | Eligard, Jatenzo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $30.10 | 2024 | |
| Botanix Sb INC | $28.70 | 2025 | Sofdra |
| Sumitomo Pharma America, INC. | $24.49 | 2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $24.11 | 2024 | |
| Lnhc, INC | $23.99 | 2025 | Zelsuvmi |
| Becton, Dickinson and Company | $23.89 | 2024 | Bard Urinary Drainage Bag |
| Astellas Pharma US INC | $23.58 | 2025 | Xtandi |
| Nobelpharma America, LLC | $20.99 | 2025 | |
| Antares Pharma, INC. | $18.86 | 2024 | Xyosted |
| Blue Earth Diagnostics | $18.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brenda Ocampo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.